Central Nervous System Neoplasm

Project: Every Child for Younger Patients With Cancer

Cerebrospinal Fluid Biomarkers for Brain Tumors

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Collecting and Storing Tissue From Young Patients With Cancer

An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors

Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors